title: Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device.
abstract: HeartWare is a third generation left ventricular assist device (LVAD), widely used for the management of advanced heart failure patients. These devices are frequently associated with a significant risk of gastrointestinal (GI) bleeding. The data for the management of patients with LVAD presenting with GI bleeding is limited. We describe a 56-year-old lady, recipient of a HeartWare device, who experienced recurrent GI bleeding and was successfully managed with subcutaneous (SC) formulations of octreotide.
authors.affiliation: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
authors.forename: Geetanjali
authors.initials: G
authors.lastname: Dang
authors.affiliation: Advanced Heart Failure and Transplant Cardiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
authors.forename: Ryan
authors.initials: R
authors.lastname: Grayburn
authors.affiliation: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Lamb
authors.affiliation: Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
authors.forename: Adrian
authors.initials: A
authors.lastname: Umpierrez De Reguero
authors.affiliation: Advanced Heart Failure and Transplant Cardiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
authors.forename: Nunzio
authors.initials: N
authors.lastname: Gaglianello